Dr. Benjamin Herzberg, MD
Claim this profileNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
Studies Lung Cancer
Studies Solid Tumors
7 reported clinical trials
11 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage IV
Stage II
2Solid Tumors
Stage IV
Stage III
MTAP positive
Affiliated Hospitals
Clinical Trials Benjamin Herzberg, MD is currently running
Olomorasib
for Non-Small Cell Lung Cancer
The main purpose of this study is to assess if olomorasib in combination with pembrolizumab is more effective than the pembrolizumab and placebo combination in part A in participants with resected KRAS G12C-mutant NSCLC and to assess if olomorasib in combination with durvalumab is more effective than the durvalumab and placebo combination in part B in participants with unresectable KRAS G12C-mutant non-small cell lung cancer. The study may last up to 3 years for each participant.
Recruiting1 award Phase 38 criteria
LY4066434
for Solid Tumors
The main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combination with other treatments. The study will have 2 parts: monotherapy dose escalation and dose optimization. The study is expected to last up to approximately 5 years.
Recruiting1 award Phase 14 criteria
More about Benjamin Herzberg, MD
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Benjamin Herzberg, MD has experience with
- Pembrolizumab
- IDE397
- Berzosertib
- Carboplatin
- Gemcitabine Hydrochloride
- Biospecimen Collection
Breakdown of trials Benjamin Herzberg, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin Herzberg, MD specialize in?
Benjamin Herzberg, MD focuses on Lung Cancer and Solid Tumors. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Benjamin Herzberg, MD currently recruiting for clinical trials?
Yes, Benjamin Herzberg, MD is currently recruiting for 5 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Benjamin Herzberg, MD has studied deeply?
Yes, Benjamin Herzberg, MD has studied treatments such as Pembrolizumab, IDE397, Berzosertib.
What is the best way to schedule an appointment with Benjamin Herzberg, MD?
Apply for one of the trials that Benjamin Herzberg, MD is conducting.
What is the office address of Benjamin Herzberg, MD?
The office of Benjamin Herzberg, MD is located at: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York 10032 United States. This is the address for their practice at the NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.